Gallivac Reo liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai vistām
Gallivac Reo liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai vistām
Not authorised
- Avian reovirus, strain S1133, Live
Product identification
Medicine name:
Gallivac Reo liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai vistām
Active substance:
- Avian reovirus, strain S1133, Live
Target species:
-
Chicken (for reproduction)
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Avian reovirus, strain S1133, Live10000.00/tissue culture infective dose 501.00unit(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Chicken (for reproduction)
-
Not specified0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Latvia
Package description:
- Available only in Latvian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health Italia S.p.A.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/01/1328
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
